HbA(1c) screening for new onset diabetes following acute coronary syndrome: is it a worthwhile test in clinical practice?

BACKGROUND: Diabetes and pre-diabetes are prevalent in acute coronary syndrome (ACS) and relate to adverse outcomes. This study used HbA(1c) to screen for degrees of glucose intolerance amongst patients without known diabetes presenting with ACS. METHODS: Over a 1-year period (June 2014–2015) consec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lugg, Sebastian T., May, Christine J. H., Nightingale, Peter, Tuffley, Robbie P. E., Al-Hourani, June, De, Parijat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379760/
https://www.ncbi.nlm.nih.gov/pubmed/28396850
http://dx.doi.org/10.1186/s40200-017-0296-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379760/
https://www.ncbi.nlm.nih.gov/pubmed/28396850
http://dx.doi.org/10.1186/s40200-017-0296-4

Ejemplares similares